Silphium Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Silphium Asset Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-275,000	Closed	-$10.8M	–	76
2023 Q2	$10.8M	Buy	+275,000	New	+$9.71M	4.7%	6

Silphium Asset Management's ISEE Position: Q3 2023 in Review

Silphium Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 275,000 shares — an estimated $10.8M sold.

Silphium Asset Management first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $10.8M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Silphium Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Silphium Asset Management sold 275,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $10.8M.
Silphium Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Silphium Asset Management's IVERIC bio, Inc. Common Stock position peaked at $10.8M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Silphium Asset Management's 13F filing for Q3 2023, filed 30 Jan 2025.